BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24706262)

  • 1. Overexpression of phosphorylated 4E-binding protein 1 predicts lymph node metastasis and poor prognosis of Chinese patients with hilar cholangiocarcinoma.
    Fang Z; Lu L; Tian Z; Luo K
    Med Oncol; 2014 May; 31(5):940. PubMed ID: 24706262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the Akt/mammalian target of rapamycin pathway in combined hepatocellular carcinoma and cholangiocarcinoma: significant correlation between p-4E-BP1 expression in cholangiocarcinoma component and prognosis.
    Okumura Y; Kohashi K; Tanaka Y; Kato M; Maehara Y; Ogawa Y; Oda Y
    Virchows Arch; 2020 Jun; 476(6):881-890. PubMed ID: 31927624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph Node Micrometastases are Associated with Worse Survival in Patients with Otherwise Node-Negative Hilar Cholangiocarcinoma.
    Mantel HT; Wiggers JK; Verheij J; Doff JJ; Sieders E; van Gulik TM; Gouw AS; Porte RJ
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1107-15. PubMed ID: 26178761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.
    Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J
    World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological and prognostic significance of Yes-associated protein expression in hepatocellular carcinoma and hepatic cholangiocarcinoma.
    Wu H; Liu Y; Jiang XW; Li WF; Guo G; Gong JP; Ding X
    Tumour Biol; 2016 Oct; 37(10):13499-13508. PubMed ID: 27465555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
    Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y
    PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of the mTOR pathway in intrahepatic cholangiocarcinoma.
    Wang Z; Zheng T; Wu Q; Wang J; Wu C; Wang J
    Neoplasma; 2012; 59(2):137-41. PubMed ID: 22248270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High phosphorylated 4E-binding protein 1 expression after chemoradiotherapy is a predictor for locoregional recurrence and worse survival in esophageal squamous cell carcinoma patients.
    Chao YK; Chuang WY; Yeh CJ; Chang YS; Wu YC; Kuo SY; Hsieh MJ; Hsueh C
    J Surg Oncol; 2012 Mar; 105(3):288-92. PubMed ID: 21932407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of phosphorylated 4E-binding protein 1 in non-small cell lung cancer.
    Lee HW; Lee EH; Lee JH; Kim JE; Kim SH; Kim TG; Hwang SW; Kang KW
    Int J Clin Exp Pathol; 2015; 8(4):3955-62. PubMed ID: 26097581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of phosphorylated 4E-binding protein 1 and its clinicopathological significances in gastric cancer.
    Lee HW; Park MI; Kim MS; Kim SH; Roh MS; Kim K; Jung SB; Lee EH
    Pathol Res Pract; 2015 Apr; 211(4):298-302. PubMed ID: 25661069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of ATA1/SLC38A1 predicts future recurrence and death in Chinese patients with hilar cholangiocarcinoma.
    Yu WL; Cong WM; Zhang Y; Chen Y; Wang F; Yu G
    J Surg Res; 2011 Dec; 171(2):663-8. PubMed ID: 20605601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with otherwise node-negative hilar cholangiocarcinoma.
    Tojima Y; Nagino M; Ebata T; Uesaka K; Kamiya J; Nimura Y
    Ann Surg; 2003 Feb; 237(2):201-7. PubMed ID: 12560778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Smad7 in cholangiocarcinoma: prognostic significance and implications for tumor metastasis.
    Huang Q; Liu L; Liu CH; Shao F; Xie F; Zhang CH; Hu SY
    Asian Pac J Cancer Prev; 2012; 13(10):5161-5. PubMed ID: 23244128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of Sig1R is closely associated with tumor progression and poor outcome in patients with hilar cholangiocarcinoma.
    Xu D; Yi W; Chen Y; Ma L; Wang J; Yu G
    Med Oncol; 2014 Dec; 31(12):261. PubMed ID: 25344871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of phospho-AKT1 and phospho-MTOR is associated with a favorable prognosis independent of PTEN expression in intrahepatic cholangiocarcinomas.
    Lee D; Do IG; Choi K; Sung CO; Jang KT; Choi D; Heo JS; Choi SH; Kim J; Park JY; Cha HJ; Joh JW; Choi KY; Kim DS
    Mod Pathol; 2012 Jan; 25(1):131-9. PubMed ID: 21874010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic significance of Sox2, CD44 and CD44v6 expression in intrahepatic cholangiocarcinoma.
    Gu MJ; Jang BI
    Pathol Oncol Res; 2014 Jul; 20(3):655-60. PubMed ID: 24482053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.
    Choi SB; Kim KS; Choi JY; Park SW; Choi JS; Lee WJ; Chung JB
    Ann Surg Oncol; 2009 Nov; 16(11):3048-56. PubMed ID: 19626372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The DNA index as a prognostic tool in hilar cholangiocarcinoma.
    Kamphues C; Al-Abadi N; Bova R; Rademacher S; Al-Abadi H; Klauschen F; Bahra M; Neuhaus P; Pratschke J; Seehofer D
    J Surg Oncol; 2015 Aug; 112(2):214-8. PubMed ID: 26220797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive and prognostic implications of 4E-BP1, Beclin-1, and LC3 for cetuximab treatment combined with chemotherapy in advanced colorectal cancer with wild-type KRAS: Analysis from real-world data.
    Guo GF; Wang YX; Zhang YJ; Chen XX; Lu JB; Wang HH; Jiang C; Qiu HQ; Xia LP
    World J Gastroenterol; 2019 Apr; 25(15):1840-1853. PubMed ID: 31057298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
    Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
    Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.